Daily Bulletin

Men's Weekly

.

New data independently confirms and extends laboratory findings and expands safety profile of ATH434-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

MELBOURNE, Australia and SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of...

Read more: New data independently confirms and extends laboratory findings and expands safety profile of...

More Articles ...

  1. Tile™ and Skullcandy Create Most Advanced True Wireless Finding Experience-PR Newswire APAC
  2. Trade360 Announces New Trading Platform-PR Newswire APAC
  3. Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report-PR Newswire APAC

Business News

Why Every Business Needs Wholesale Gift Boxes and Custom Packaging

candles, handmade jewellery and artisanal chocolates are just some item types where aesthetics are important to shape customer assumptions in terms of brand prestige or product quality. Pack aging ...

Daily Bulletin - avatar Daily Bulletin

How Local Service Businesses in Australia Can Compete (and Win) Online

Source: Pexels Running a local business today means competing not just on your street but online, too. It’s no secret that big brands dominate search results and social feeds, leaving many Australi...

Daily Bulletin - avatar Daily Bulletin

Why Small Business is the Latest Casualty of the Cost-of-Living Crisis

The Australian small to medium enterprise (SME) sector is currently navigating a systemic crisis defined by the convergence of high operational costs and severely constrained consumer demand. This env...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business